Our Portfolio

Nathan Kline Institute

Suzana Petanceska, PhD | NY, United States

Project Overview

  • Academic/Nonprofit Organization Type
  • $360,742 Funding Amount
  • 12/22/00 — 11/2/04 Project Duration
  • Drug Discovery Program
  • Target Validation Therapeutic Stage
  • Closed Status

Nathan Kline Institute

Suzana Petanceska, PhD | NY, United States

Pharmacogenetic effects of human apoE on the amyloid-reducing activity of cholesterol lowering drugs in a transgenic mouse model for Alzheimer's disease

GET IN TOUCH